Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel +/-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 29; pp. viii206 - viii207
Main Authors Barbour, A.P., Walpole, E.T., Mai, G.T., Barnes, L., Watson, D.I., Ackland, S.P., Wills, V., Martin, J., Burge, M., Karapetis, C.S., Shannon, J., Nott, L.M., Gebski, V., Oostendorp, M., Wilson, K., Thomas, J., Lampe, G., Zalcberg, J.R., Simes, J., Smithers, M.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2018
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy282.003